P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG-TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN-LABEL EXTENSION

P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG-TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN-LABEL EXTENSION

Bibliographic Details
Main Authors: A. Röth, M. Egyed, S. Ichikawa, Y. Ito, J. S. Kim, Z. Nagy, N. Obara, J. Panse, H. Schrezenmeier, S. Sica, J. Soret, K. Usuki, S.-S. Yoon, K. Benkali, M. Buri, P. Lundberg, H. Patel, K. Shinomiya, S. Sreckovic, J.-I. Nishimura
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000846204.59341.a5

Similar Items

Similar Items